Fundraising FoxEpidarex Capital — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Hawkhill Therapeuticshawkhilltherapeutics.comApr 2026SEC filingmedium confidence
BiotechDundee, Scotland
Timothy Jason Sparey(Executive Officer)Antoine Boulanger(Executive Officer)Francisca Peixoto(Executive Officer)Christopher Andrew Woodland(Executive Officer, Director)
Board seatMary Canning· per SEC Form D · $290.5K raise · filed Sep 2026
Co-investorsO2h Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.